Responses
Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
49 High efficient circulating tumor cells (CTCs) mutation detection in cancer patients using targeted panel sequencing
Compose a Response to This Article
Other responses
No responses have been published for this article.
